Pelthos Therapeutics Inc. is launching Moms Against Molluscum, a movement to unite mothers, parents, and other caregivers who are navigating molluscum contagiosum.
The Moms Against Molluscum movement encourages people managing this skin infection to visit MomsAgainstMolluscum.com, share their stories, and access information about new treatment options, including berdazimer topical gel, 10.3% (Zelsuvmi, Pelthos Therapeutics Inc).
“I commend the team at Pelthos for bringing families and caregivers together to discuss the emotional, logistical, and social burden of this highly contagious skin infection. I have seen firsthand the toll molluscum takes on parents, especially when it spreads within families. I hope this movement will encourage people to talk to their physicians about new treatment options,” says Stephen W. Stripling, MD, a Pediatrician at The Medical University of South Carolina in Charleston, SC, in a news release.
For more information on the Moms Against Molluscum movement, visit www.momsagainstmolluscum.com. To share your stories on social media, use the hashtag #MomsAgainstMolluscum.
“Preventing the spread of molluscum can be a significant burden on parents and caregivers. We hope that this movement will spark more discussions about this skin infection and educate families about ZELSUVMI, the first FDA-approved at-home treatment for molluscum,” says Scott Plesha, CEO of Pelthos.
“This is about putting an end to the wondering, the waiting, and the loneliness that comes with a diagnosis of molluscum,” adds Toni Morgan, a parent. “Now that we can take action and treat the condition conveniently, at home or on the go, treating molluscum is something we can work on together. I don’t want other parents to have to deal with this alone, as I have in the past. We are now able to build a supportive, positive community around this experience.”
